BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34087381)

  • 1. Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.
    Sharma S; Carlson S; Gregory-Flores A; Hinojo-Perez A; Olson A; Thippeswamy T
    Neurobiol Dis; 2021 Aug; 156():105410. PubMed ID: 34087381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.
    Sharma S; Carlson S; Puttachary S; Sarkar S; Showman L; Putra M; Kanthasamy AG; Thippeswamy T
    Neurobiol Dis; 2018 Feb; 110():102-121. PubMed ID: 29197620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T
    Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Src tyrosine kinase inhibitor, saracatinib, on the markers of epileptogenesis in a mixed-sex cohort of adult rats in the kainic acid model of epilepsy.
    Rao NS; Putra M; Meyer C; Almanza A; Thippeswamy T
    Front Mol Neurosci; 2023; 16():1294514. PubMed ID: 38025259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice.
    Luo XM; Zhao J; Wu WY; Fu J; Li ZY; Zhang M; Lu J
    BMC Neurosci; 2021 Jan; 22(1):2. PubMed ID: 33451301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy.
    Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A
    Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase Fyn promotes osteoarthritis by activating the β-catenin pathway.
    Li K; Zhang Y; Zhang Y; Jiang W; Shen J; Xu S; Cai D; Shen J; Huang B; Li M; Song Q; Jiang Y; Liu A; Bai X
    Ann Rheum Dis; 2018 Jun; 77(6):935-943. PubMed ID: 29555825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
    Kaufman AC; Salazar SV; Haas LT; Yang J; Kostylev MA; Jeng AT; Robinson SA; Gunther EC; van Dyck CH; Nygaard HB; Strittmatter SM
    Ann Neurol; 2015 Jun; 77(6):953-71. PubMed ID: 25707991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.
    Putra M; Sharma S; Gage M; Gasser G; Hinojo-Perez A; Olson A; Gregory-Flores A; Puttachary S; Wang C; Anantharam V; Thippeswamy T
    Neurobiol Dis; 2020 Jan; 133():104443. PubMed ID: 30940499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
    Klee R; Brandt C; Töllner K; Löscher W
    Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis.
    Ramazi S; Fahanik-Babaei J; Mohamadi-Zarch SM; Tashakori-Miyanroudi M; Nourabadi D; Nazari-Serenjeh M; Roghani M; Baluchnejadmojarad T
    J Chem Neuroanat; 2020 Oct; 108():101800. PubMed ID: 32430101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam.
    Kienzler-Norwood F; Costard L; Sadangi C; Müller P; Neubert V; Bauer S; Rosenow F; Norwood BA
    Epilepsia; 2017 Feb; 58(2):222-230. PubMed ID: 28157273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy.
    Vasanthi SS; Rao NS; Samidurai M; Massey N; Meyer C; Gage M; Kharate M; Almanza A; Wachter L; Mafuta C; Trevino L; Carlo AM; Bryant E; Corson BE; Wohlgemuth M; Ostrander M; Showman L; Wang C; Thippeswamy T
    J Neuroinflammation; 2023 Jul; 20(1):163. PubMed ID: 37438764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fyn kinase inhibitor, AZD0530, suppresses mouse alcohol self-administration and seeking.
    Morisot N; Berger AL; Phamluong K; Cross A; Ron D
    Addict Biol; 2019 Nov; 24(6):1227-1234. PubMed ID: 30536923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
    Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
    Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cardiac structure and function is related to seizure frequency in a rat model of chronic acquired temporal lobe epilepsy.
    Powell KL; Liu Z; Curl CL; Raaijmakers AJA; Sharma P; Braine EL; Gomes FM; Sivathamboo S; Macefield VG; Casillas-Espinosa PM; Jones NC; Delbridge LM; O'Brien TJ
    Neurobiol Dis; 2021 Nov; 159():105505. PubMed ID: 34520843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying effects of a novel T-type calcium channel antagonist, Z944, in a model of temporal lobe epilepsy.
    Casillas-Espinosa PM; Shultz SR; Braine EL; Jones NC; Snutch TP; Powell KL; O'Brien TJ
    Prog Neurobiol; 2019 Nov; 182():101677. PubMed ID: 31419467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
    Zeng LH; Rensing NR; Wong M
    J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats.
    Yang JJ; Liu YX; Wang YF; Ge BY; Wang Y; Wang QS; Li S; Zhang JJ; Jin LL; Hong JS; Yin SM; Zhao J
    Neurosci Bull; 2024 May; 40(5):577-593. PubMed ID: 37973720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
    Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
    Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.